GlassScriptPhysician profile
Brittney Watts
NPI 1972293561
$777.89
in general payments reported to CMS, 2019-2025
10 companies · $652 in 2025
The $652 reported for 2025 was more than what 81% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.42 · 2024: $107 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $488 · Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $488.40 |
| Food and Beverage | $289.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $576.40 | 2025 | |
| Merck Sharp & Dohme LLC | $47.44 | 2024-2025 | Keytruda, Welireg |
| Bioventus LLC | $25.57 | 2025 | Xcell |
| Alexion Pharmaceuticals, INC. | $25.42 | 2024 | Ultomiris |
| Avanos Medical | $20.93 | 2025 | On-Q Pump and Accessories |
| Eisai INC. | $19.42 | 2023 | |
| Daiichi Sankyo INC. | $17.93 | 2024 | Injectafer |
| Abbvie INC. | $17.05 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.56 | 2024 | Tagrisso |
| Myriad Genetic Laboratories, INC. | $13.17 | 2024 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Watts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.